• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

News

Biomimesys

Development of cerebral in vitro 3D models: update about Veronique’s PhD thesis

There are 90% of failure in clinical trials, mainly due to safety and efficiency issues. In particular, the central nervous system is involved in 34% of failure in clinical trials, but only in 7% of failure in preclinical trials (Cook et al., 2014). That points a lack of relevance in Read more…

By Véronique De Conto, 5 months3 months ago
Biomimesys

Thomas joins us to work on breast cancer

It’s pleasure to welcome Thomas in our team. After a four-month internship at the CrCHUM (Centre de recherche du Centre Hospitalier de l’Université de Montréal, Canada) in the field of microfluidic personalized medicine for prostate cancer, he joined us in September for a six- months-internship, as part of his Master’s Read more…

By Grégory MAUBON, 5 months3 months ago
HCS, HCA & Biology

Cell-ECM Mechanobiology: why interdisciplinary fields?

Cells and the extracellular matrix (ECM): what is the relationship between them? This is a fundamental question. We hear many reflections about this question. Should we let cells work alone, or should we force cells to form an aggregate when working in vitro? Do cells need a specific and relevant Read more…

By Zied Souguir, 5 months5 months ago
Biomimesys

Great success for BIOMIMESYS® presentation at Academia Sinica (Taiwan)

We are really proud to work on a real partnership with the team of Tokyo Future Style (TFS) Taïwan for almost a year now. Joseph Chou, member of our business advisory board and Pr John Lo, member of our scientific advisory board, have fully understood the value of BIOMIMESYS® our Read more…

By Grégory MAUBON, 5 months3 months ago
Biomimesys

Sandrine joins HCS Pharma to develop BIOMIMESYS® sales

We are very pleased to welcome Sandrine in HCS Pharma team. With multiple decades in cell culture products sales in the life sciences market for various major companies, Sandrine PONCET brings to HCS Pharma an essential asset to develop and support BIOMIMESYS® sales in the national and international academic and Read more…

By Grégory MAUBON, 6 months3 months ago
Biomimesys

Back to work with a significant change for HCS Pharma: focus on in vitro 3D cell culture as close as possible to real human organs

You may have noticed on our website: we have changed our logo this summer, and it is the most visible part of our strategic development. Of course, we are always experts in HCS and cell imaging but, for us, it is the perfect time to show our deep expertise in Read more…

By Grégory MAUBON, 6 months3 months ago
Biomimesys

We welcome Julien to strengthen our BIOMIMESYS® production capacities

We are very pleased to welcome Julien in our team. Julien has a bachelor’s degree in control and expertise analysis. He started his carrer in the pharmaceutical industry and he continued in chemical industry where he acquired strong skills in quality management. Now he has joined HCS Pharma to work Read more…

By Grégory MAUBON, 6 months3 months ago
Biomimesys

What is the microenvironment of a neuron?

The human brain contains approximately 86 billon neurons of different types, distributed and organized in different areas ; their functions vary according to the neuron type and its localization within the brain. However, the neuronal function also depends on its microenvironment, which is composed of the extracellular matrix (ECM), and Read more…

By Véronique De Conto, 9 months3 months ago
Biomimesys

Vaihere joins us to work on cerebral in vitro model including microenvironment

Vaihere Cheung obtained her technology baccalaureate in Sciences and Laboratory Techniques (STL) in 2018 at La Mennais, in French Polynesia. Afterwards, she came to Metropolitan France to pursue her studies in biological engineering at the Technological Institute in Lyon University. In this context, she performed an internship in two laboratories Read more…

By Véronique De Conto, 9 months3 months ago
News

HCS Pharma selected in Female Founder Challenge of Vivatechnology

Among 370 applications from 54 countries, I am proud to be selected with 9 other start-ups for Female Founder Challenge organized by Vivatechnology & 50inTech. We are to women frmn France. “In Europe, 92% of the funds were invested in startups founded by men. The tech sector needs to be Read more…

By Nathalie MAUBON, 9 months3 months ago
Biomimesys

Let’s talk about BIOMIMESYS® uses (by our partners)

As we are involved in some very interesting projects, we have the chance to work with amazing specialists in many field. All these people help us to make the BIOMIMESYS® technology better, easier to use and well adapted to their work. We asked them to explain why they use BIOMIMESYS® Read more…

By Grégory MAUBON, 9 months3 months ago
News

We are confined but we always work with you in 3D cell culture!

Dear all, We  hope this email finds you, your family and colleagues well!  We are available to discuss with you: about your needs in high content screening/analysis services. We would be happy to organise videoconferences and phone calls to see how imaging can foster your R&D, by testing the safety Read more…

By Grégory MAUBON, 10 months3 months ago
Biomimesys

BIOMIMESYS® is now distributed in Europe by Dominique Dutscher SAS

Our BIOMIMESYS® products are now available in the Dominique Dutscher’s catalogue. We are very happy to work with such a famous company ! Founded in 1982 in Alsace (France) Dominique Dutscher SAS is specialized in the distribution of laboratory consumables and equipment for research, biotechnology and health. We share with Read more…

By Grégory MAUBON, 10 months3 months ago
Biomimesys

Hyaluronic acid importance in brain extracellular matrix

The brain extracellular matrix (ECM) has a specific composition. Contrary to other organs, this ECM contains a low level of fibrous proteins, like collagen and fibronectin. Actually it is mainly composed of proteoglycans, which are composed of sulfated glycosaminoglycans (GAGs) covalently bound to a core protein. Hayluronic acid (HA), a Read more…

By Véronique De Conto, 10 months3 months ago
News

Our contribution to the Laval Virtual magazine on Health

Immersive technologies (XR) are playing an increasingly important role in many areas of the healthcare sector. In HCS Pharma we monitor this progress and we have used these technologies many times, for example at the installation of our robotic platform. Then we were very happy when Laval Virtual, one of Read more…

By Grégory MAUBON, 11 months3 months ago
Nanostem

We welcome Elisa who works on the human Blood-Brain Barrier in vitro

Elisa Moya started her bachelor’s degree in 2013, in Biological Sciences, at the University of Granada, Spain. During her career period, in 2015, she studied one year in Portugal (Erasmus+). Moreover, in the summer 2016, she participated during 3 months in a research project dealing with Alzheimer’s disease in Newcastle Read more…

By Grégory MAUBON, 11 months3 months ago
HCS, HCA & Biology

Extracellular Matrix and Cerebral Diseases

The extracellular matrix (ECM) is composed of macromolecules surrounding the cells. They interact with each other and with the cells, cross-link and polymerize, ensuring the maintenance and the function of organs. The primary role of ECM is to support the cells by providing adhesion support, but its role goes beyond: Read more…

By Véronique De Conto, 11 months11 months ago
News

Karine Hannebique, surgeon on breast cancer, joins our Scientific Advisory Board

Dr. Karine Hannebicque has joined our Scientific Advisory Board. She is a surgeon in breast cancer and reconstructive surgery working in Oscar Lambret Center in the Department of breast oncology since 2013. She is also Medical Coordinator of the Ambulatory Surgery Unit since 2018. After her Internship in Obstetrics & Read more…

By Nathalie MAUBON, 11 months3 months ago
News

Prof. Szecheng J. Lo (Chang-Gung University,Taiwan) joins our Scientific Advisory Board

We are really happy to welcome Prof. Lo in our Scientific Advisory Board. Prof. Lo has a huge experiment in hepatitis infection and liver diseases with more than 120 publications in this field. With help of Joseph Chou (CEO of Tokyo Future Style Taiwan), Pr Lo leads all R&D programs Read more…

By Nathalie MAUBON, 12 months3 months ago
News

Elise joins us an in vitro model of skin microbiota

As part of the validation of her Master’s degree in biotechnology (University of Lille), specializing in cellular and molecular engineering, Elise recently joined HCS Pharma. After having completed three internships from one to four months in the fields of immunology and microbiology, in France and abroad, she joined the team Read more…

By Grégory MAUBON, 12 months3 months ago
News

COVID-19 pandemic impacts HCS Pharma activities

As many companies in France and in the world, the COVID-19 pandemic deeply affects our activities. For safety reasons, most of our work is now done remotely but we maintain essential activity in laboratories to take care of our cells and try to finish our ongoing customer studies. The situation Read more…

By Grégory MAUBON, 12 months3 months ago
News

We will attend HCS User Meeting by Molecular Devices in Leiden next week

We will give a presentation next week (on Tuesday, 10th of March 2020) at the High-Content Cellular Imaging User meeting organized by our partner Molecular Devices, which will take place in Leiden (Netherlands). It is a great pleasure for us to attend the meeting, and to talk about the applications, Read more…

By Elodie Vandenhaute, 1 year5 days ago
News

Meet Meryl in Rennes at the next “Liver Week”

The 8th edition of the Symposium of “Functional Genomics of the Liver” (GFF) will be held from 26 to 28 February 2020 in Rennes, at the Couvent des Jacobins. Meryl, from our team, will be present with a poster about hiPSCs-derived liver organoids made with BIOMIMESYS® Liver hydroscaffold. If you Read more…

By Grégory MAUBON, 1 year3 months ago

Posts navigation

Previous 1 2 3 … 19 Next
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • How to create physiologically-relevant 3D in vitro models using BIOMIMESYS® hydroscaffold
  • The skin microbiota, a fundamental part of in vitro studies
  • Agrément CIR jusqu’en 2023 pour HCS Pharma
  • Oxidative stress : definition and biological effects
  • On the importance of extracellular matrix of the skin for efficient 3D cell culture models
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2020 | Hestia | Powered by WordPress